GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » PB Ratio

Pentixapharm Holding AG (XTER:PTP) PB Ratio : 1.74 (As of Mar. 30, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2025-03-30), Pentixapharm Holding AG's share price is €3.25. Pentixapharm Holding AG's Book Value per Share for the quarter that ended in Jun. 2024 was €1.86. Hence, Pentixapharm Holding AG's PB Ratio of today is 1.74.

The historical rank and industry rank for Pentixapharm Holding AG's PB Ratio or its related term are showing as below:

XTER:PTP' s PB Ratio Range Over the Past 10 Years
Min: 1.43   Med: 1.63   Max: 2.4
Current: 1.7

During the past 3 years, Pentixapharm Holding AG's highest PB Ratio was 2.40. The lowest was 1.43. And the median was 1.63.

XTER:PTP's PB Ratio is ranked better than
61.06% of 1279 companies
in the Biotechnology industry
Industry Median: 2.37 vs XTER:PTP: 1.70

Back to Basics: PB Ratio


Pentixapharm Holding AG PB Ratio Historical Data

The historical data trend for Pentixapharm Holding AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG PB Ratio Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23
PB Ratio
- - -

Pentixapharm Holding AG Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
PB Ratio - - - - -

Competitive Comparison of Pentixapharm Holding AG's PB Ratio

For the Biotechnology subindustry, Pentixapharm Holding AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pentixapharm Holding AG's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's PB Ratio falls into.


;
;

Pentixapharm Holding AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Pentixapharm Holding AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=3.25/1.864
=1.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Pentixapharm Holding AG  (XTER:PTP) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Pentixapharm Holding AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pentixapharm Holding AG Business Description

Traded in Other Exchanges
N/A
Address
Robert-Rossle-Street 10, Berlin, DEU
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines